Sarah Gheuens is Chief Medical Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 43,736 shares of AGIO, which is worth approximately $2.52 Million. The most recent transaction as insider was on Dec 02, 2021, when has been sold 834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.7K
0% 3M change
81.03% 12M change
Total Value Held $2.52 Million

Sarah Gheuens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2021
BUY
Exercise of conversion of derivative security
-
834 Added 16.26%
4,296 Common Stock

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
SG

Sarah Gheuens

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO